Timoptic (Timolol Maleate Ophthalmic) - Summary

TIMOPTIC SUMMARY

TIMOPTIC® in OCUDOSE®
0.25% AND 0.5% (TIMOLOL MALEATE OPHTHALMIC SOLUTION)
PRESERVATIVE-FREE STERILE OPHTHALMIC SOLUTION
in a Sterile Ophthalmic Unit Dose Dispenser

TIMOPTIC (timolol maleate ophthalmic solution) is a non-selective beta-adrenergic receptor blocking agent.

Timoptic Ophthalmic Solution is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.

See all Timoptic indications & dosage >>

TIMOPTIC NEWS HIGHLIGHTS

Published Studies Related to Timoptic (Timolol Ophthalmic)

Intraocular pressure-lowering efficacy of brinzolamide 1%/timolol 0.5% fixed combination compared with brinzolamide 1% and timolol 0.5%. [2008.10]

Effects of the timolol-dorzolamide fixed combination and latanoprost on circadian diastolic ocular perfusion pressure in glaucoma. [2008.10]

Comparison of ocular hypotensive effect and safety of brinzolamide and timolol added to latanoprost. [2008.04]

Bimatoprost/timolol fixed combination: a 3-month double-masked, randomized parallel comparison to its individual components in patients with glaucoma or ocular hypertension. [2008.04]

Meta-analysis of randomized controlled trials comparing timolol with brimonidine in the treatment of glaucoma. [2008.04]

more >>

Clinical Trials Related to Timoptic (Timolol Ophthalmic)

MK0507A Phase III Double-Blind, Comparative Study [Completed]

24-Hour IOP Control With Dorzolamide/Timolol and Latanoprost/Timolol Fixed Combination in Open-Angle Glaucoma [Completed]

Comparison of Latanoprost Vs. Timolol [Recruiting]

Effect of Xalacom® (Latanoprost/Timolol) and Combigan® (Brimonidine/Timolol) Fixed Combination on Intraocular Pressure and Ocular Blood Flow in Patients With Primary Open Angle Glaucoma or Ocular Hypertension [Recruiting]

Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension [Completed]

more >>